Krystal Biotech submitted an application in August seeking approval for the initiation of a Phase I clinical trial of KB408. After a 30-day review...
FDA Approves Saptalis Pharmaceuticals’ LIKMEZ, a New Form of Metronidazole
The FDA has approved the brand name LIKMEZ for ATI-1501, a new formulation of the antibiotic metronidazole. ATI-1501, developed by Appili Therapeutics, is a...
Medicines for Europe prepares for Ukraine’s forthcoming membership in the European Union (EU).
Medicines for Europe held a meeting in Brussels with a high-level Ukrainian government delegation, led by Maryna Slobodnichenko, Deputy Minister of Health for European...
G-BA decisions from 21 September 2023
Here are the decisions made by the G-BA during their meeting on September 21, 2023, regarding the early benefit assessments of various medications:Nubeqa...
Roche has procured two RNA-targeted drug programs for Alzheimer's and Huntington's diseases from Ionis Pharmaceuticals. The acquisition deal involves a $60 million upfront payment...
